What We Do

Collaborating to Move Cancer Care Forward

We believe every patient living with advanced cancer should benefit from comprehensive genomic information to inform their care. That’s why we’ve built a powerful portfolio of comprehensive genomic profiling (CGP) tests that—via both blood and tissue samples—evaluate more than 300 genes known to drive cancer.

Our History

Following the completion of the Human Genome Project and the launch of the Cancer Genome Atlas, Foundation Medicine’s founders envisoned a world where all cancer patient could benefit from genomic insights at the point of care, and that with a deeper, molecular-level understanding of this disease, we could fundamentally transform the way cancer is treated.

From this idea—democratizing the power of molecular information to benefit patients around the world—Foundation Medicine was born.

Contact supplier

Stay in the loop!